Proionic® Medical System, an exclusive technology from INDIBA®
INDIBA® unique focus on the study of ion exchange and electric cell potential has led to the Proionic® Medical CRet System, a technology which increases the biostimulation whilst fully respecting natural cell physiology.
Pioneers in diathermy and experts in monopolar radiofrequency
Since 1983 INDIBA® has been dedicated to the research and development of medical devices by the desire to enhance the care of the human body through scientific advancement.
- Diathermy: induction of local hyperthermia by radiofrequency waves that increase the localised blood flow and induce biological effects that are beneficial either medically or aesthetically. It’s applied through electrodes placed on the surface of the patient’s skin.
- Monopolar radiofrequency: the Proionic® Medical CRet System patented by INDIBA® works at 448 kHz, the appropriate frequency for correct mobilisation of ions.
Nowadays, INDIBA® continues to innovate by constantly improving the applications available to the medical community and meeting the specific needs of patients, doctors and health therapists.
Launch in 2017 (Europe)
All the world